2-hydroxyglutarate (2-HG), an oncometabolite caused by IDH mutations that frequently occur in gliomas and acute myeloid leukemia, led to genome-wide histone and DNA methylation alterations (132). The gene discussed is IDH2; the disease is acute myeloid leukemia.